Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03DUY
|
||||
Former ID |
DCL001165
|
||||
Drug Name |
BMS-833923
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Exelixis; Bristol-Myers Squibb
|
||||
Structure |
Download2D MOL |
||||
Formula |
C30H27N5O
|
||||
InChI |
InChI=1S/C30H27N5O/c1-20-12-13-21(19-31-2)18-27(20)33-29(36)23-14-16-24(17-15-23)32-30-34-26-11-7-6-10-25(26)28(35-30)22-8-4-3-5-9-22/h3-18,31H,19H2,1-2H3,(H,33,36)(H,32,34,35)
|
||||
InChIKey |
KLRRGBHZCJLIEL-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | smoothened receptor | Target Info | Inhibitor | [550635] | |
PANTHER Pathway | Hedgehog signaling pathway | ||||
Pathway Interaction Database | Signaling events mediated by the Hedgehog family | ||||
Hedgehog signaling events mediated by Gli proteins | |||||
References | |||||
Ref 542996 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8202). | ||||
Ref 550635 | Clinical pipeline report, company report or official report of Exelixis (2011). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.